Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Karen Marie, Nykjaer"'
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy
Externí odkaz:
https://doaj.org/article/580d645001d84888b6f1a279ad1a72a7
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
Introduction. Small intestinal neuroendocrine tumours (NETs) have increased in incidence during the past decades. In recent years, new promising treatment modalities have been introduced. The aim of the present study was to characterize and compare p
Externí odkaz:
https://doaj.org/article/477d25afd2c04cdb8e715b3c0eaa1c79
Publikováno v:
BMC Nephrology
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139, pp. 1-6 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139 . https://doi.org/10.1186/s12882-019-1336-8
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, pp. 139 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139, pp. 1-6 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139 . https://doi.org/10.1186/s12882-019-1336-8
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, pp. 139 . https://doi.org/10.1186/s12882-019-1336-8
BACKGROUND: An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy or risks
Publikováno v:
Nephrology Dialysis Transplantation. 33:i95-i95
Autor:
Søren Nielsen, Henrik Vase, Thomas Larsen, Thomas G. Lauridsen, Karen Marie Nykjær, Pia Holland Gjørup, Solveig Klok Matthesen, Erling B. Pedersen
Publikováno v:
Matthesen, S K, Larsen, T, Lauridsen, T G, Vase, H, Gjørup, P H, Nykjær, K M, Nielsen, S & Pedersen, E B 2012, ' Effect of amiloride and spironolactone on renal tubular function, ambulatory blood pressure, and pulse wave velocity in healthy participants in a double-blinded, randomized, placebo-controlled, crossover trial ', Clinical and Experimental Hypertension, vol. 34, no. 8, pp. 588-600 . https://doi.org/10.3109/10641963.2012.681730
We wanted to test the hypothesis that treatment with amiloride or spironolactone reduced ambulatory (ABP) and central blood pressure (CBP) and that tubular transport via ENaCγ and AQP2 was increased after furosemide treatment. During baseline condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961ccdd3e4ee4d1216dc53c51c6e15b2
https://pure.au.dk/portal/da/publications/effect-of-amiloride-and-spironolactone-on-renal-tubular-function-ambulatory-blood-pressure-and-pulse-wave-velocity-in-healthy-participants-in-a-doubleblinded-randomized-placebocontrolled-crossover-trial(ea744a45-36fd-4a25-a6b6-37d0a31c855a).html
https://pure.au.dk/portal/da/publications/effect-of-amiloride-and-spironolactone-on-renal-tubular-function-ambulatory-blood-pressure-and-pulse-wave-velocity-in-healthy-participants-in-a-doubleblinded-randomized-placebocontrolled-crossover-trial(ea744a45-36fd-4a25-a6b6-37d0a31c855a).html
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
Hoej, L B, Nykjær, K M & Gronbaek, H 2012, ' Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center ' Scientific World Journal, vol. 2012, pp. 206350 . https://doi.org/10.1100/2012/206350
The Scientific World Journal
Hoej, L B, Nykjær, K M & Gronbaek, H 2012, ' Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center ' Scientific World Journal, vol. 2012, pp. 206350 . https://doi.org/10.1100/2012/206350
The Scientific World Journal
Introduction. Small intestinal neuroendocrine tumours (NETs) have increased in incidence during the past decades. In recent years, new promising treatment modalities have been introduced. The aim of the present study was to characterize and compare p
Autor:
Karen Marie, Nykjaer, Henning, Grønbaek, Dennis Tønner, Nielsen, Peer, Christiansen, Lone Bording, Astrup
Publikováno v:
In vivo (Athens, Greece). 21(4)
We have initiated a clinical database of patients with neuroendocrine tumours (n = 132). Data on patients with well-differentiated endocrine carcinoma (WHO classification) previous classified as midgut carcinoid patients, are presented.Retrospectivel
Autor:
Solveig Klok Matthesen, Erling B. Pedersen, Pia Holland Gjørup, Henrik Vase, Søren Nielsen, Thomas G. Lauridsen, Karen Marie Nykjær, Thomas Larsen
Publikováno v:
Journal of Hypertension. 30:e214-e215
Autor:
Karen Marie Nykjær, Solveig Klok Matthesen, Pia Holland Gjørup, Henrik Vase, Erling B. Pedersen, Thomas G. Lauridsen, Thomas Larsen
Publikováno v:
Journal of Hypertension. 29:e365
Autor:
Matthesen, Solveig Klok1,2 (AUTHOR) Solveig.Klok.Matthesen@vest.rm.dk, Larsen, Thomas1,2 (AUTHOR), Lauridsen, Thomas Guldager1,2 (AUTHOR), Vase, Henrik1,2 (AUTHOR), Gjørup, Pia Holland1,2 (AUTHOR), Nykjær, Karen Marie1,2 (AUTHOR), Nielsen, Søren3 (AUTHOR), Pedersen, Erling Bjerregaard1,2 (AUTHOR)
Publikováno v:
Clinical & Experimental Hypertension. Dec2012, Vol. 34 Issue 8, p588-600. 13p.